Surprise change of CEO at GSK; ‘Moral hazard’ fears over Jaguar Land Rover’s £1.5bn state loan guarantee – business live

Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.

GSK’s Emma Walmsley to be replaced as chief executive

Inside the Jaguar Land Rover hack: stalled smart factories, outsourced cybersecurity and supply chain woes

GSK’s pharmaceuticals rival, AstraZeneca, also has news this morning.

AstraZeneca has shaken up its stock market listing structure, and will now have a direct listing on the New York stock market, as well as in London and Stockholm.

“Today we set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, Stockholm and New York.

Enabling a global listing structure will allow us to reach a broader mix of global investors and will make it even more attractive for all our shareholders to have the opportunity to participate in AstraZeneca’s exciting future.”